2026 ICD-10-CM Diagnosis Code J65Pneumoconiosis associated with tuberculosis

ICD-10-CM CodesJ00–J99J60-J70J65

ICD-10-CM J65
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

J65 is a billable ICD-10-CM diagnosis code for pneumoconiosis associated with tuberculosis. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 196 through 198. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Lung disease due to external agents and Tuberculosis.

For Medicare Advantage risk adjustment, J65 maps to CMS-HCC Category 280 (Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders) under the V28 model, adding a risk factor of about 0.319 for a community, non-dual, aged beneficiary in payment year 2026.

Code Identity

ICD-10-CM Code
J65
Billable Status
Yes — Valid for Submission
Code Describes
Pneumoconiosis associated with tuberculosis
Short Description
Pneumoconiosis associated with tuberculosis
Same as the full description in the CMS dataset.
Chapter
J60-J70
Lung diseases due to external agents

Code Classification

ChapterJ00–J99Diseases of the respiratory system
SectionJ60-J70Lung diseases due to external agents
CategoryJ65Pneumoconiosis associated with tuberculosis
This CodeJ65Pneumoconiosis associated with tuberculosis

Medicare Risk Adjustment (HCC)Billing

J65 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2026.

CMS-HCC V28 Category (Payment Model)
HCC 280— Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders
Payment HCC · PY 2026 one of 79 ICD-10-CM codes in this category
Risk Adjustment Factor (RAF) Weight
+0.319
community, non-dual, aged · ranges 0.209–0.390 across segments
Hierarchy
Superseded by HCC 276, HCC 277, HCC 278, and HCC 279
a more severe related category takes the payment when both are reported
Prior Model (CMS-HCC V24)
HCC 112
V24 retired V28 pays 100% of MA risk scores since PY 2026
Other CMS Models
PACE (CMS-HCC V22): HCC 112 · ESRD (V21): HCC 112 · ESRD (V24): HCC 112
ESRD V21 weights: 0.066 dialysis, 0.281–0.299 functioning graft · ESRD V24 weights: 0.058 dialysis, 0.080–0.256 functioning graft
Part D (RxHCC)
Not mapped
J65 does not risk-adjust in the RxHCC prescription drug model

Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Pneumoconiosis associated with tuberculosis
  • Pneumoconiosis caused by silica
  • Silicotuberculosis

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Any condition in J60 J64 A15
  • Silicotuberculosis

Use Additional Code

  • code, if applicable, for associated cachexia E88.A

Index to Diseases and InjuriesGuidance

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR RSP013
Lung disease due to external agents
Default principal diagnosis: inpatient Yes · outpatient Yes
CCSR INF001
Tuberculosis
Default principal diagnosis: inpatient No · outpatient No

Clinical InformationClinical

  • Silicotuberculosis

    pulmonary or extrapulmonary infection caused by mycobacterium tuberculosis or nontuberculous mycobacteria in a patient with silicosis.
  • Mycobacterium tuberculosis

    a species of gram-positive, aerobic bacteria that produces tuberculosis in humans, other primates, cattle; dogs; and some other animals which have contact with humans. growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.

Patient EducationClinical

Interstitial Lung Diseases

Interstitial lung disease is the name for a large group of diseases that inflame or scar the lungs. The inflammation and scarring make it hard to get enough oxygen. The scarring is called pulmonary fibrosis.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert J65 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
505 Pneumoconiosis NOS
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About J65Overview

What is the ICD-10 code for pneumoconiosis associated with tuberculosis?

The ICD-10-CM code for pneumoconiosis associated with tuberculosis is J65. It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

Is J65 (Pneumoconiosis associated with tuberculosis) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report pneumoconiosis associated with tuberculosis on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does J65 group to?

When pneumoconiosis associated with tuberculosis is the principal diagnosis on an inpatient stay, it groups to MS-DRG 196, 197, 198, with relative weights from 0.7162 to 1.8872 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of J65?

Under the General Equivalence Mappings, pneumoconiosis associated with tuberculosis converts to ICD-9-CM 505 (pneumoconiosis NOS). The mapping is approximate, so confirm the match fits the documentation.

What HCC is J65?

J65 (pneumoconiosis associated with tuberculosis) maps to CMS-HCC Category 280 (Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders), commonly written as HCC 280, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2026. It mapped to HCC 112 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. It does not map to any RxHCC in the Part D prescription drug model.

Does J65 risk-adjust for Medicare Advantage payment?

Yes. When documented and reported on a Medicare Advantage encounter, J65 adds a risk adjustment factor of about 0.319 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.209 to 0.390 depending on the payment segment). A more severe related category (HCC 276, HCC 277, HCC 278, and HCC 279) supersedes it when both are reported. See the full factor table on the HCC 280 category page.